Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed) Inc.verified

MNMD

Price:

$7.56

Market Cap:

$554.39M

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.[Read more]

Industry

Biotechnology

IPO Date

2016-11-15

Stock Exchange

NASDAQ

Ticker

MNMD

The Enterprise Value as of November 2024 (TTM) for Mind Medicine (MindMed) Inc. (MNMD) is 283.41M

According to Mind Medicine (MindMed) Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 283.41M. This represents a change of 52.95% compared to the average of 185.30M of the last 4 quarters.

Mind Medicine (MindMed) Inc. (MNMD) Historical Enterprise Value (quarterly & annually)

How has MNMD Enterprise Value performed in the past?

The mean historical Enterprise Value of Mind Medicine (MindMed) Inc. over the last ten years is 127.90M. The current 283.41M Enterprise Value has changed 22.06% with respect to the historical average. Over the past ten years (40 quarters), MNMD's Enterprise Value was at its highest in in the June 2021 quarter at 1.24B. The Enterprise Value was at its lowest in in the December 2022 quarter at -58515900.80.

Quarterly (TTM)
Annual

Average

127.90M

Median

314.03K

Minimum

-74183581.40

Maximum

731.88M

Mind Medicine (MindMed) Inc. (MNMD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Mind Medicine (MindMed) Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 293.18%

Maximum Annual Enterprise Value = 731.88M

Minimum Annual Increase = -177.84%

Minimum Annual Enterprise Value = -74183581.40

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202357.74M-177.84%
2022-74183581.40-117.13%
2021433.17M-40.81%
2020731.88M293.18%
2019249.55K-20.53%
2018314.03K-78.35%
20171.45M456.00%
2016260.84K-0.59%

Mind Medicine (MindMed) Inc. (MNMD) Average Enterprise Value

How has MNMD Enterprise Value performed in the past?

The current Enterprise Value of Mind Medicine (MindMed) Inc. (MNMD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

138.91M

5-year avg

229.77M

10-year avg

127.90M

Mind Medicine (MindMed) Inc. (MNMD) Enterprise Value vs. Peers

How is MNMD’s Enterprise Value compared to its peers?

Mind Medicine (MindMed) Inc.’s Enterprise Value is greater than Cybin Inc. (120.27M), greater than Seelos Therapeutics, Inc. (10.08M), less than GH Research PLC (392.97M), greater than Awakn Life Sciences Corp. (4.81M), greater than Atai Life Sciences N.V. (264.01M), greater than Freeline Therapeutics Holdings plc (2.82M), greater than Bio-Path Holdings, Inc. (3.00M), greater than Vaccinex, Inc. (6.56M), greater than Eliem Therapeutics, Inc. (119.64M), less than Opthea Limited (514.42M), greater than Molecular Partners AG (132.68M), less than Edgewise Therapeutics, Inc. (3.01B), greater than iTeos Therapeutics, Inc. (185.75M), greater than Checkpoint Therapeutics, Inc. (175.79M), greater than Mustang Bio, Inc. (7.08M), greater than Reviva Pharmaceuticals Holdings, Inc. (33.37M), greater than Fortress Biotech, Inc. (57.12M), greater than Kodiak Sciences Inc. (201.31M),

Build a custom stock screener for Mind Medicine (MindMed) Inc. (MNMD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mind Medicine (MindMed) Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mind Medicine (MindMed) Inc. (MNMD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mind Medicine (MindMed) Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Mind Medicine (MindMed) Inc.'s Enterprise Value?

What is the highest Enterprise Value for Mind Medicine (MindMed) Inc. (MNMD)?

What is the 3-year average Enterprise Value for Mind Medicine (MindMed) Inc. (MNMD)?

What is the 5-year average Enterprise Value for Mind Medicine (MindMed) Inc. (MNMD)?

How does the current Enterprise Value for Mind Medicine (MindMed) Inc. (MNMD) compare to its historical average?